# A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

> **NCT04778514** · NA · COMPLETED · sponsor: **Population Council** · enrollment: 30 (actual)

## Conditions studied

- HIV Infections
- Contraception

## Interventions

- **DRUG:** Dual Prevention Pill
- **DRUG:** PrEP and combined oral contraceptive (COC) as two separate tablets

## Key facts

- **NCT ID:** NCT04778514
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-07
- **Primary completion:** 2023-09-11
- **Final completion:** 2023-09-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778514, "A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04778514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*